Well, this is a little scary-- my clinical trial coordinator had to call all of us, since Genentech announced a third case of PML (progressive multifocal leukoencephalopathy, a usually fatal brain disease) in a person taking rituximab for rheumatoid arthritis. They're just making calls to let people know, even though the study I'm in is a modified rituximab one, using ocrelizumab,a "humanized" MAb. As my coordinator put it, this makes 3 cases out of 100000 or so.
I like those odds. But it is a reminder that these drugs are WAY powerful. alas, not treating my MS is not an option! So tomorrow, back to PHX, more blood work, more MRI! Joy!
Click on the post title for the news on the PML case.